The hypoxia-inducible factor (Hif)-1α (Hif-1α) and Hif-2α (Epas1) have a critical role in both normal development and cancer. von Hippel Lindau (Vhl) protein, encoded by a tumor suppressor gene, is an E3 ubiquitin ligase that targets Hif-1α and Epas1 to the proteasome for degradation. To better understand the role of Vhl in the biology of mesenchymal cells, we analyzed mutant mice lacking Vhl in mesenchymal progenitors that give rise to the soft tissues that form and surround synovial joints. Loss of Vhl in mesenchymal progenitors of the limb bud caused severe fibrosis of the synovial joints and formation of aggressive masses with histologic features of mesenchymal tumors. Hif-1α and its downstream target connective tissue growth factor wer...
Von Hippel-Lindau (VHL) disease is caused by germline mutations in the VHL tumor suppressor gene, wi...
Adaptation to low oxygen, or hypoxia, is primarily mediated by hypoxia-inducible factor (HIF) protei...
Recently, work on the mechanism of action of the von Hippel-Lindau tumour suppressor protein (pVHL) ...
The hypoxia-inducible factor (Hif)-1α (Hif-1α) and Hif-2α (Epas1) have a critical role in both norma...
The hypoxia-inducible factor (Hif)-1\u3b1 (Hif-1\u3b1) and Hif-2\u3b1 (Epas1) have a critical role i...
International audienceThe hypoxia-inducible factor (Hif)-1α (Hif-1α) and Hif-2α (Epas1) have a criti...
AbstractInactivation of the von Hippel-Lindau (VHL) gene is associated with the development of highl...
Adaptation to low oxygen tension (hypoxia) is a critical event during development. The transcription...
nactivating mutations within the von Hippel-Lindau tumor suppressor gene predispose patients to deve...
Patients with germline mutations in the tumor suppressor, VHL , are predisposed to the development o...
AbstractAdaptation to low oxygen tension (hypoxia) is a critical event during development. The trans...
Inactivating mutations of the von Hippel-Lindau gene (VHL) on chromosome 3p have been associated wit...
AbstractThe physiologic response to changes in cellular oxygen tension is ultimately governed by a h...
Ubiquitin ligase von Hippel-Lindau tumor suppressor (pVHL) negatively regulates protein levels of hy...
The physiologic response to changes in cellular oxygen tension is ultimately governed by a heterodim...
Von Hippel-Lindau (VHL) disease is caused by germline mutations in the VHL tumor suppressor gene, wi...
Adaptation to low oxygen, or hypoxia, is primarily mediated by hypoxia-inducible factor (HIF) protei...
Recently, work on the mechanism of action of the von Hippel-Lindau tumour suppressor protein (pVHL) ...
The hypoxia-inducible factor (Hif)-1α (Hif-1α) and Hif-2α (Epas1) have a critical role in both norma...
The hypoxia-inducible factor (Hif)-1\u3b1 (Hif-1\u3b1) and Hif-2\u3b1 (Epas1) have a critical role i...
International audienceThe hypoxia-inducible factor (Hif)-1α (Hif-1α) and Hif-2α (Epas1) have a criti...
AbstractInactivation of the von Hippel-Lindau (VHL) gene is associated with the development of highl...
Adaptation to low oxygen tension (hypoxia) is a critical event during development. The transcription...
nactivating mutations within the von Hippel-Lindau tumor suppressor gene predispose patients to deve...
Patients with germline mutations in the tumor suppressor, VHL , are predisposed to the development o...
AbstractAdaptation to low oxygen tension (hypoxia) is a critical event during development. The trans...
Inactivating mutations of the von Hippel-Lindau gene (VHL) on chromosome 3p have been associated wit...
AbstractThe physiologic response to changes in cellular oxygen tension is ultimately governed by a h...
Ubiquitin ligase von Hippel-Lindau tumor suppressor (pVHL) negatively regulates protein levels of hy...
The physiologic response to changes in cellular oxygen tension is ultimately governed by a heterodim...
Von Hippel-Lindau (VHL) disease is caused by germline mutations in the VHL tumor suppressor gene, wi...
Adaptation to low oxygen, or hypoxia, is primarily mediated by hypoxia-inducible factor (HIF) protei...
Recently, work on the mechanism of action of the von Hippel-Lindau tumour suppressor protein (pVHL) ...